国产人妖网站在线免费观看|伊人久久大杳蕉亚洲无码AV影视|91婷婷五月天|日韩毛片在线视频观看

世界生命科學(xué)前沿動態(tài)周報(四十五)

2011年-05月-01日 來源:mebo

(4.25-5.1/2011)
美寶國際集團:陶國新  


        主要內(nèi)容:正常細胞和腫瘤細胞能夠自發(fā)轉(zhuǎn)變?yōu)楦杉毎麡訝顟B(tài);發(fā)現(xiàn)能夠?qū)⑻囟毎D(zhuǎn)變?yōu)樯a(chǎn)胰島素的細胞的機制;通過激活成熟神經(jīng)元中的BMP/Smad1信號通路再生受傷脊椎中的軸突神經(jīng);線粒體作治療癌癥的靶點;小分子協(xié)同作用維持人體胚胎干細胞早期分化后的長期穩(wěn)定自我更新;鑒別出與肌肉修復(fù)有關(guān)的關(guān)鍵基因。

1. 正常細胞和腫瘤細胞能夠自發(fā)轉(zhuǎn)變?yōu)楦杉毎麡訝顟B(tài)
【動態(tài)】
目前的干細胞生物學(xué)模型假定正常干細胞和腫瘤干細胞都是位于細胞層次結(jié)構(gòu)的頂端,單向分化形成非干細胞的后代。美國MIT的科學(xué)家發(fā)現(xiàn)一類不符合該假設(shè)的人基底樣乳腺上皮細胞能夠自發(fā)逆轉(zhuǎn)變成干細胞樣細胞。而且,致癌性轉(zhuǎn)化增強這一自發(fā)轉(zhuǎn)變,因而在體內(nèi)外由非干細胞的癌細胞能夠產(chǎn)生腫瘤干細胞樣細胞。他們進一步研究表明正常起始細胞的分化狀態(tài)很大程度上決定著它轉(zhuǎn)變后的行為。這些發(fā)現(xiàn)說明正常細胞和腫瘤干細胞樣細胞能夠從分化更充分的細胞全新產(chǎn)生,乳腺干細胞生物學(xué)的層次模型應(yīng)該包含干細胞與非干細胞的雙向互變。這一可塑性或許能促成不需操控基因而生產(chǎn)患者特有成體干細胞的方法,對于制定根除癌癥的治療策略也有重要意義。

【點評】
 該發(fā)現(xiàn)說明非干細胞可以自發(fā)轉(zhuǎn)變成干細胞,這一點在潛能再生細胞早已體現(xiàn)。另外,普通腫瘤細胞也可以自發(fā)轉(zhuǎn)變成腫瘤干細胞,這使得癌癥并不是可以通過除掉腫瘤干細胞就能治愈。

【參考論文】 PNAS, 2011; DOI: 10.1073/pnas.1102454108
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Christine L. Chaffer, Ines Brueckmann, Christina Scheel, et al.
Current models of stem cell biology assume that normal and neoplastic stem cells reside at the apices of hierarchies and differentiate into nonstem progeny in a unidirectional manner. Here we identify a subpopulation of basal-like human mammary epithelial cells that departs from that assumption, spontaneously dedifferentiating into stem-like cells. Moreover, oncogenic transformation enhances the spontaneous conversion, so that nonstem cancer cells give rise to cancer stem cell (CSC)-like cells in vitro and in vivo. We further show that the differentiation state of normal cells-of-origin is a strong determinant of posttransformation behavior. These findings demonstrate that normal and CSC-like cells can arise de novo from more differentiated cell types and that hierarchical models of mammary stem cell biology should encompass bidirectional interconversions between stem and nonstem compartments. The observed plasticity may allow derivation of patient-specific adult stem cells without genetic manipulation and holds important implications for therapeutic strategies to eradicate cancer.

2. 發(fā)現(xiàn)能夠?qū)⑻囟毎D(zhuǎn)變?yōu)樯a(chǎn)胰島素的細胞的機制
【動態(tài)】  
  盡管作為當前糖尿病的標準療法的胰島素治療能夠幫助患者維持血糖水平,但并不完美,許多患者依舊有很高的風險患上各種并發(fā)癥?;謴?fù)缺失的生產(chǎn)胰島素的β細胞對于1型和2型糖尿病可能會是更徹底的解決方案。胰腺β細胞身份靠DNA甲基化介導(dǎo)的Arx抑制來維持。刪除Dnmt1導(dǎo)致β 細胞重組為 α 細胞。在β細胞中Arx被抑制,而該抑制被去除會使β細胞轉(zhuǎn)變?yōu)棣良毎?。在成長中和受傷后成熟的胰腺β細胞會復(fù)制以維持血糖的穩(wěn)定。發(fā)現(xiàn)缺乏在細胞分裂中傳送DNA甲基化模式的酶Dnmt1的β細胞轉(zhuǎn)變成了α細胞。鑒別出細胞系決定基因Arx, Arx在β細胞中是甲基化和被抑制的,在α細胞和缺乏Dnmt1的β細胞中是低甲基化并表達的。β細胞中Arx的甲基化位點結(jié)合了甲基結(jié)合蛋白MeCP2,該蛋白招募甲基化組蛋白H3R2的酶PRMT6導(dǎo)致Arx的抑制。這表明在細胞分裂中傳送DNA甲基化也保證了能夠修飾和傳遞組蛋白標記的酶機制的啟用。新的研究結(jié)果揭示了在細胞分裂中傳送DNA甲基化是抑制α 細胞系決定基因維持β細胞身份所必須的。


【點評】
胰腺β細胞轉(zhuǎn)變?yōu)棣良毎臋C制說明DNA甲基化等表觀調(diào)控是決定細胞生命屬性的重要因素,單只DNA本身并不能決定細胞的生命屬性。這也為合理調(diào)節(jié)表觀調(diào)控以影響細胞生命屬性提供了科學(xué)依據(jù)。

【參考論文】Developmental Cell, 2011; 20 (4): 419 DOI:10.1016/j.devcel.2011.03.012
Pancreatic β Cell Identity Is Maintained by DNA Methylation-Mediated Repression of Arx
Sangeeta Dhawan, Senta Georgia, Shuen-ing Tschen, Guoping Fan, Anil Bhushan
Adult pancreatic β cells can replicate during growth and after injury to maintain glucose homeostasis. Here, we report that β cells deficient in Dnmt1, an enzyme that propagates DNA methylation patterns during cell division, were converted to α cells. We identified the lineage determination gene aristaless-related homeobox (Arx), as methylated and repressed in β cells, and hypomethylated and expressed in α cells and Dnmt1-deficient β cells. We show that the methylated region of the Arx locus in β cells was bound by methyl-binding protein MeCP2, which recruited PRMT6, an enzyme that methylates histone H3R2 resulting in repression of Arx. This suggests that propagation of DNA methylation during cell division also ensures recruitment of enzymatic machinery capable of modifying and transmitting histone marks. Our results reveal that propagation of DNA methylation during cell division is essential for repression of α cell lineage determination genes to maintain pancreatic β cell identity.


3.通過激活成熟神經(jīng)元中的BMP/Smad1信號通路再生受傷脊椎中的軸突神經(jīng)
【動態(tài)】
  軸突生長潛力在年輕神經(jīng)元中最高但隨年齡增長而消失,因而成為成體受傷后軸突再生的顯著障礙。一項新研究表明在DRG神經(jīng)元中Smad1依賴的骨成型蛋白(BMP)逐步被調(diào)節(jié)控制軸突生長。下調(diào)該途徑造成年齡相關(guān)的軸突生長潛力的下降。在成熟的DRG神經(jīng)元中選擇性重新激活Smad1導(dǎo)致脊椎損傷的老鼠模型感覺神經(jīng)再生。Smad1信號可以通過臨床適用的最小侵入技術(shù)運送編碼BMP4的AAV載體來有效的操控。重要的是,即使是脊椎損傷后實施AAV治療,斷了的軸突也能再生,因此很像相應(yīng)的臨床事件。

【點評】
  這一神經(jīng)再生的研究也說明DNA并非決定細胞生命活動的關(guān)鍵,對基因表達的調(diào)控更重要。

【參考論文】PNAS 2011, doi: 10.1073/pnas.1100426108
Regeneration of axons in injured spinal cord by activation of bone morphogenetic protein/Smad1 signaling pathway in adult neurons
Pranav Parikha, Yuhan Haoa, Mohsen Hosseinkhania.
Axon growth potential is highest in young neurons but diminishes with age, thus becoming a significant obstacle to axonal regeneration after injury in maturity. The mechanism for the decline is incompletely understood, and no effective clinical treatment is available to rekindle innate growth capability. Here, we show that Smad1-dependent bone morphogenetic protein (BMP) signaling is developmentally regulated and governs axonal growth in dorsal root ganglion (DRG) neurons. Down-regulation of the pathway contributes to the age-related decline of the axon growth potential. Reactivating Smad1 selectively in adult DRG neurons results in sensory axon regeneration in a mouse model of spinal cord injury (SCI). Smad1 signaling can be effectively manipulated by an adeno-associated virus (AAV) vector encoding BMP4 delivered by a clinically applicable and minimally invasive technique, an approach devoid of unwanted abnormalities in mechanosensation or pain perception. Importantly, transected axons are able to regenerate even when the AAV treatment is delivered after SCI, thus mimicking a clinically relevant scenario. Together, our results identify a therapeutic target to promote axonal regeneration after SCI.


4.  線粒體作治療癌癥的靶點
【動態(tài)】  
有關(guān)癌細胞線粒體的一些研究引導(dǎo)了發(fā)展針對線粒體蛋白和功能的無遺傳毒性的抗癌療法。目前已經(jīng)明確的線粒體在細胞凋亡中的作用提供了腫瘤細胞自殺的新靶點。線粒體的作用是作為對細胞壓力和損傷做出反應(yīng)的中央轉(zhuǎn)換器。可以針對癌細胞中導(dǎo)致免于凋亡的那些變化來抑制其增殖。因為癌細胞代謝的重組涉及到增加糖酵解,看起來通過針對HIF-1 或HIF-1基因編碼的代謝酶來阻斷InsP3R Ca2+的釋放或響應(yīng)缺氧的適應(yīng)性途徑代表了一種可行的癌癥治療方法。在體外向癌細胞添加白藜蘆醇后很快發(fā)生的是細胞內(nèi)數(shù)秒內(nèi)即可測到的Ca2+的增多。在添加無毒的類黃酮時也觀察到Ca2+的釋放,看來值得找出鈣活化中涉及的模型化合物白藜蘆醇的作用靶點。


【點評】
針對癌細胞線粒體與正常細胞線粒體的差異進行癌癥治療的思路是對的,但是目前這種差異的細節(jié)還不是很清楚。

【參考論文】Journal of cellular physiology. 2011 DOI 10.1002/jcp.22788
Targeting mitochondria as a therapeutic target in cancer
Wenner CE
Knowledge of re-programming in cancer cells with metabolic differences from their normal counterparts has resulted in new examination of therapeutic approaches. Several studies of the role of tumor mitochondria in cancer have led to the development of non-genotoxic therapies which target mitochondrial proteins, function. The now well-established functions of mitochondria in apoptosis provide novel targets for tumor cell suicide. Mitochondria serve as a central hub for responses to cellular stress as well as injury. The alterations in cancer cells which result in protection from apoptosis can be targeted to inhibit proliferation. Because of the reprogramming of cancer cell metabolism involving increased glycolysis, it appears that blocking InsP3R Ca2+ release or adaptive pathways in response to hypoxia by targeting HIF-1 or metabolic enzymes encoded by the HIF-1 gene represents a feasible therapeutic approach to cancer. A very early in vitro event found in tumor cells following resveratrol addition is an increase in intracellular Ca2+, measurable within seconds. Ca2+ release is also observed with non-toxic flavonoids and a goal to identify the sentinel targets of resveratrol as a model compound involved in calcium activation seems worthwhile. New findings of the relationship between autophagy and apoptosis are discussed. The contribution of ROS generated by mitochondria is also considered. New data as to how cyclophilins and VDAC are involved in mitochondrial hexokinase protection of factors that induce apoptosis are reviewed. In addition, chemotherapeutic approaches based on Aktactivated mTORC1 are described, and their relationship to the role of aerobic glycolysis in this protection.

 

5.  小分子協(xié)同作用維持人體胚胎干細胞早期分化后的長期穩(wěn)定自我更新
【動態(tài)】
    小分子抑制劑迅速誘導(dǎo)人體胚胎干細胞轉(zhuǎn)變?yōu)樵忌窠?jīng)祖細胞并維持長期自我更新。人體胚胎干細胞賦予了再生醫(yī)學(xué)巨大希望。通常人體胚胎干細胞的應(yīng)用需要其在體外分化成期望的均一細胞群。目前的人體胚胎干細胞分化模式面臨的一個主要挑戰(zhàn)是不能有效鎖定并長期穩(wěn)定擴增那些保有廣泛的分化能力,更重要的是發(fā)育階段特異性的分化傾向的原始的細胞系特異性干細胞/祖細胞群。一項新的研究報告了用小分子協(xié)同抑制糖原合成酶激酶3(GSK3),轉(zhuǎn)化生長因子β (TGF-β),和Notch信號途徑能夠在特定化學(xué)條件下于一周內(nèi)有效的將單層培養(yǎng)的人體胚胎干細胞轉(zhuǎn)變成均一的原始神經(jīng)上皮細胞。這些原始神經(jīng)上皮能夠在白細胞抑制因子,GSK3抑制劑(CHIR99021)和TGF-β受體抑制劑(SB431542)存在的情況下穩(wěn)定的自我更新;保持高潛力的神經(jīng)生長能力和對中腦后腦神經(jīng)亞型引導(dǎo)性神經(jīng)模式線索的反應(yīng)性;并表現(xiàn)出體內(nèi)的整體性。

【點評】
通過小分子抑制劑協(xié)同作用調(diào)控不同的信號途徑,來達到阻止干細胞進一步分化和維持干細胞長期穩(wěn)定擴增,對于干細胞體外培養(yǎng)還是有些價值的,只是這種人為規(guī)定的環(huán)境下培育的干細胞能否發(fā)揮體內(nèi)正常生理條件下的干細胞功能還有很大疑問。


【參考論文】PNAS 2011 ; doi:10.1073/pnas.1014041108
Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors
Wenlin Li, Woong Sun, Yu Zhang, et al.
Human embryonic stem cells (hESCs) hold enormous promise for regenerative medicine. Typically, hESC-based applications would require their in vitro differentiation into a desirable homogenous cell population. A major challenge of the current hESC differentiation paradigm is the inability to effectively capture and, in the long-term, stably expand primitive lineage-specific stem/precursor cells that retain broad differentiation potential and, more importantly, developmental stage-specific differentiation propensity. Here, we report synergistic inhibition of glycogen synthase kinase 3 (GSK3), transforming growth factor β (TGF-β), and Notch signaling pathways by small molecules can efficiently convert monolayer cultured hESCs into homogenous primitive neuroepithelium within 1 wk under chemically defined condition. These primitive neuroepithelia can stably self-renew in the presence of leukemia inhibitory factor, GSK3 inhibitor (CHIR99021), and TGF-β receptor inhibitor (SB431542); retain high neurogenic potential and responsiveness to instructive neural patterning cues toward midbrain and hindbrain neuronal subtypes; and exhibit in vivo integration. Our work uniformly captures and maintains primitive neural stem cells from hESCs.

6.  鑒別出與肌肉修復(fù)有關(guān)的關(guān)鍵基因
【動態(tài)】
    作為胚胎骨骼肌發(fā)育的關(guān)鍵,衛(wèi)星細胞(SCs)直至嬰兒期還在繼續(xù)活躍的增加肌肉質(zhì)量。之后,他們數(shù)量逐漸減少并沉寂下來,直到損傷或退化激活它們增殖。衛(wèi)星細胞維持肌肉生長并使成熟的骨骼肌具有強大的再生能力。一項新的研究報告了Polycomb抑制性復(fù)合物2(PRC2)的酶亞基EZH2,在Pax7+/Myf5− 干細胞和 Pax7+/Myf5+ 肌原性前體細胞中都有表達,并且是保持衛(wèi)星細胞池穩(wěn)定所需要的。有條件的切除SCs的Ezh2的老鼠出生后Pax7+細胞很少且肌肉數(shù)量下降還不能適當再生。這些缺陷與受損的SC增殖及非肌細胞中表達的基因的去抑制有聯(lián)系。因此,EZH2在SCs中控制自我更新和增殖以及維持合適的轉(zhuǎn)錄程序。


【點評】
該研究對衛(wèi)星細胞的增殖規(guī)律以及肌肉損傷后修復(fù)有了更深入的了解,有助于損傷和衰老肌肉復(fù)原的研究。

【參考論文】Genes Dev., 25:789%u2013794 DOI:10.1101/gad.2027911
Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells
Juan AH, Derfoul A, Feng X, et al.
Satellite cells (SCs) sustain muscle growth and empower adult skeletal muscle with vigorous regenerative abilities. Here, we report that EZH2, the enzymatic subunit of the Polycomb-repressive complex 2 (PRC2), is expressed in both Pax7+/Myf5− stem cells and Pax7+/Myf5+ committed myogenic precursors and is required for homeostasis of the adult SC pool. Mice with conditional ablation of Ezh2 in SCs have fewer muscle postnatal Pax7+ cells and reduced muscle mass and fail to appropriately regenerate. These defects are associated with impaired SC proliferation and derepression of genes expressed in nonmuscle cell lineages. Thus, EZH2 controls self-renewal and proliferation, and maintains an appropriate transcriptional program in SCs.